Published in Arthritis Rheum on August 01, 1990
Yellow Fever Vaccine in Patients With Rheumatic Diseases | NCT03430388
Prospective Longitudinal Cohort Study of Vasculitis Patients (VASCO) | NCT04413331
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis (2006) 3.68
Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis. Rheumatology (Oxford) (2014) 1.62
New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol (2013) 1.59
123I-MIBG imaging detects cardiac involvement and predicts cardiac events in Churg-Strauss syndrome. Eur J Nucl Med Mol Imaging (2010) 1.43
Churg-Strauss syndrome. Thorax (2000) 1.27
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. Ann Rheum Dis (2004) 1.26
Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol (2014) 1.24
Effects of in utero exposure to street drugs. Am J Public Health (1993) 1.24
Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides. PLoS One (2012) 1.23
A new international classification of childhood vasculitis. Pediatr Nephrol (2006) 1.22
Eosinophilic pneumonias. Clin Microbiol Rev (2012) 1.20
Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatry (2007) 1.13
Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol (2008) 1.05
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement. Nephrol Dial Transplant (2011) 1.04
Coronary involvement in the Churg-Strauss syndrome. Heart (1997) 1.04
Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology (Oxford) (2010) 1.03
Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry (1998) 1.03
Severe eosinophilic syndrome associated with the use of probiotic supplements: a new entity? Case Rep Rheumatol (2012) 1.00
Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS). Clin Exp Immunol (2011) 0.98
A case of Churg-Strauss syndrome revealed by eosinophilic gastroenteritis. Dig Dis Sci (2008) 0.97
Churg-Strauss syndrome in a child: retina and optic nerve findings. Br J Ophthalmol (2004) 0.95
Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol (2014) 0.95
Acute coronary syndrome associated with Churg-Strauss syndrome. Vasc Health Risk Manag (2007) 0.94
Churg-Strauss syndrome (CSS) in a patient receiving pranlukast. Clin Rheumatol (2003) 0.93
Rapid progressive eosinophilic cardiomyopathy in a patient with Churg-Strauss syndrome (CSS). Clin Res Cardiol (2006) 0.93
A Case of Loeffler's Endocarditis Associated with Churg-Strauss Syndrome. J Cardiovasc Ultrasound (2010) 0.93
Repressed ileal artery aneurysms in Churg-Strauss syndrome following combination treatment with glucocorticoid and cyclophosphamide. Rheumatol Int (2008) 0.93
Therapeutic approaches to patients with hypereosinophilic syndromes. Semin Hematol (2012) 0.92
Bowel perforations in a patient affected by Churg-Strauss syndrome under high-dose steroid treatment: will alternative drugs reduce risk of surgery? Rheumatol Int (2009) 0.92
Multiple cerebral infarctions in a patient with Churg-Strauss syndrome. J Neurol (2010) 0.92
Central retinal artery occlusion in an ANCA negative Churg-Strauss syndrome patient. Int Ophthalmol (2007) 0.92
Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis. Biomed Res Int (2016) 0.92
Paranasal sinus inflammation and non-specific orbital inflammatory syndrome: an uncommon association. Graefes Arch Clin Exp Ophthalmol (2006) 0.90
Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss). PLoS One (2015) 0.89
Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS J (2012) 0.89
Acute painless monocular visual loss due to central retinal artery occlusion in a patient with Churg-Strauss vasculitis. Clin Rheumatol (2007) 0.89
Retracted Increased serum high mobility group box-1 level in Churg-Strauss syndrome. Clin Exp Immunol (2007) 0.89
Clinical review: Vasculitis on the intensive care unit--part 1: diagnosis. Crit Care (2004) 0.89
Churg-Strauss vasculitis presenting with severe visual loss due to bilateral sequential optic neuropathy. Br J Ophthalmol (1993) 0.89
Rituximab in Churg-Strauss syndrome. Ann Rheum Dis (2006) 0.89
Pulmonary findings in Churg-Strauss syndrome in chest X-rays and high resolution computed tomography at the time of initial diagnosis. Clin Rheumatol (2010) 0.89
Spectrum of Eosinophilic End-Organ Manifestations. Immunol Allergy Clin North Am (2015) 0.89
Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings. Eur Radiol (2007) 0.88
A patient with hypereosinophilic syndrome that manifested with acquired hemophilia and elevated IgG4: a case report. J Med Case Rep (2012) 0.88
Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients. Autoimmune Dis (2011) 0.88
Non-infectious orbital vasculitides. Eye (Lond) (2012) 0.88
Double-balloon endoscopy-diagnosed multiple small intestinal ulcers in a Churg-Strauss syndrome patient. World J Gastrointest Endosc (2012) 0.87
Churg-Strauss syndrome with critical endomyocardial fibrosis: 10 year survival after combined surgical and medical management. Heart (2002) 0.87
Carbimazole-induced lupus. BMJ Case Rep (2013) 0.87
Challenges in diagnosis of isolated central nervous system vasculitis. Brain Behav (2011) 0.86
Difficult asthma or Churg-Strauss syndrome? BMJ (1999) 0.86
Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome. Ann Rheum Dis (2006) 0.86
Involvement of soluble CD95 in Churg-Strauss syndrome. Am J Pathol (1999) 0.86
Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal. Heart (2001) 0.85
Peripheral neuropathy as initial manifestation of primary systemic vasculitides. J Neurol (2012) 0.85
Clinical utility of cardiac magnetic resonance imaging in Churg-Strauss syndrome: case report and review of the literature. Rheumatol Int (2008) 0.85
A fatal case of Churg-Strauss syndrome presenting with acute polyneuropathy mimicking Guillain-Barré syndrome. Neurol Sci (2011) 0.83
Cardiac involvement of churg-strauss syndrome as a reversible cause of dilated cardiomyopathy. J Cardiovasc Ultrasound (2015) 0.83
Focused microarray analysis of peripheral mononuclear blood cells from Churg-Strauss syndrome patients. DNA Res (2008) 0.83
Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome. Allergy (2012) 0.83
Allergic granulomatosis and angiitis in the absence of asthma and blood eosinophilia: a rare presentation of limited Churg-Strauss syndrome. Rheumatol Int (2003) 0.83
A case of Churg-Strauss vasculitis complicated by small bowel necrosis. Postgrad Med J (1993) 0.83
Sinonasal involvement in systemic vasculitides and cocaine-induced midline destructive lesions: Diagnostic controversies. Allergy Rhinol (Providence) (2013) 0.82
A case of nephrotic syndrome in a patient with Churg-Strauss syndrome. Rheumatol Int (2009) 0.82
Acute fulminant neuropathy in a patient with Churg-Strauss syndrome. Postgrad Med J (1997) 0.82
Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. Clin Exp Immunol (2010) 0.82
Rare manifestations of Churg-Strauss syndrome: coronary artery vasospasm, temporal artery vasculitis, and reversible monocular blindness-a case report. Clin Rheumatol (2008) 0.82
Clinical features and prognostic factors of Churg-Strauss syndrome. Korean J Intern Med (2014) 0.82
Effective intravenous immunoglobulin therapy for Churg-Strauss syndrome (allergic granulomatous angiitis) complicated by neuropathy of the eighth cranial nerve: a case report. J Med Case Rep (2012) 0.82
A pseudoleukemic blood differentiation in a 13-year-old child: an extraordinary presentation of Churg-Strauss syndrome. Clin Rheumatol (2009) 0.82
Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab. Am J Hematol (2014) 0.82
Churg-Strauss syndrome presented as paraneoplastic syndrome with thymic neuroendocrine carcinoma: a case report. Rheumatol Int (2011) 0.81
[ANCA-associated vasculitis]. Z Rheumatol (2013) 0.81
Churg-strauss syndrome and active chronic hepatitis B virus infection: coincidence or association? Clinics (Sao Paulo) (2010) 0.81
Subarachnoid and intracerebral hemorrhage in patients with churg-strauss syndrome: two case reports. J Cerebrovasc Endovasc Neurosurg (2012) 0.81
An uncommon presentation of eosinophilic granulomatosis with polyangiitis: a case report. J Med Case Rep (2014) 0.81
A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus. Arthritis Res Ther (2012) 0.81
Churg-Strauss presenting as acute coronary syndrome: sometimes it's zebras. BMJ Case Rep (2011) 0.81
Polyangiitis overlap syndrome of granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). BMJ Case Rep (2014) 0.81
Evolution to dilated cardiomyopathy from acute eosinophilic pancarditis in Churg-Strauss syndrome. Heart Vessels (1997) 0.81
Churg-Strauss syndrome complicated by colon erosion, acalculous cholecystitis and liver abscesses. World J Gastroenterol (2005) 0.80
Marked improvement of Churg-Strauss vasculitis with intravenous gamma globulins during pregnancy. Clin Rheumatol (2007) 0.80
Are classification criteria for vasculitis useful in clinical practice? Observations and lessons from Colombia. J Autoimmune Dis (2009) 0.80
Congestive cardiomyopathy and endobronchial granulomas as manifestations of Churg-Strauss syndrome. Postgrad Med J (1995) 0.80
Postpartum Churg-Strauss syndrome with severe cardiac involvement: description of a case and review of the literature. Clin Rheumatol (2009) 0.80
Churg-Strauss syndrome associated with leukotriene receptor antagonists. Ulster Med J (2001) 0.80
Imaging of systemic vasculitis in childhood. Pediatr Radiol (2015) 0.80
ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol (2016) 0.80
Magnetic resonance imaging of the cardiac manifestations of Churg-Strauss. JRSM Open (2014) 0.79
Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy. Z Kardiol (2005) 0.79
Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome. Thorax (1999) 0.79
Multi-system mitochondrial disorder with recurrent steroid-responsive eosinophilia. Rheumatol Int (2009) 0.79
A case of MPO-ANCA-positive polyarteritis nodosa complicated by exudative otitis media, mononeuritis multiplex, and acute renal failure. Clin Exp Nephrol (2011) 0.79
[Churg-Strauss syndrome]. Z Rheumatol (2008) 0.79
A laryngeal presentation of Churg-Strauss syndrome in childhood. Ann Saudi Med (2009) 0.78
Subarachnoid haemorrhage as the first clinical manifestation of Churg-Strauss syndrome. J Neurol (2008) 0.78
Neurologic manifestations of childhood rheumatic diseases. Iran J Child Neurol (2012) 0.78
Difficult-to-control asthma management through the use of a specific protocol. Clinics (Sao Paulo) (2010) 0.78
Churg-strauss syndrome without respiratory symptoms in a child. Indian J Dermatol (2011) 0.78
Eosinophilic granulomatosis with polyangiitis and diffuse gastrointestinal involvement. Case Rep Gastroenterol (2014) 0.78
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (1993) 15.54
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A (1997) 13.47
Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med (1992) 13.29
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science (1986) 11.74
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med (1983) 10.09
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86
Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med (1988) 9.21
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum (1990) 8.92
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum (1990) 8.67
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med (1983) 8.26
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum (1990) 8.23
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (1989) 7.90
Toward an understanding of the correlates of protective immunity to HIV infection. Science (1996) 7.59
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science (1987) 7.22
The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med (1978) 7.17
Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med (1986) 6.52
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med (1985) 6.46
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med (1984) 6.45
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A (1989) 6.32
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A (1989) 6.32
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol (1989) 6.02
Takayasu arteritis. Ann Intern Med (1994) 5.94
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature (1990) 5.86
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A (1998) 5.48
New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med (1993) 5.32
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol (1986) 5.19
Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med (1976) 5.16
The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum (1990) 5.09
Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J Virol (1986) 5.05
Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc (1978) 4.92
The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest (1974) 4.90
Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) (1973) 4.89
Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature (1990) 4.87
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med (2000) 4.83
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat Med (1999) 4.81
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med (1988) 4.81
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci U S A (1990) 4.80
A simple method of sample size calculation for linear and logistic regression. Stat Med (1998) 4.74
Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med (1996) 4.72
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med (1982) 4.70
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol (1996) 4.45
The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum (1990) 4.43
Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U S A (1991) 4.23
HIV. An elusive soluble suppressor. Nature (1995) 4.18
Capturing the patient's view of change as a clinical outcome measure. JAMA (1999) 4.11
Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med (1980) 3.81
Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science (1986) 3.80
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol (1997) 3.79
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77
Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology (1989) 3.60
Re-emergence of HIV after stopping therapy. Nature (1999) 3.54
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50
Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med (1975) 3.48
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol (1988) 3.45